International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announces new Director General
Geneva, 2 December 2016 – On 29 November 2016, Thomas B. Cueni was appointed Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the organization representing biopharmaceutical companies as well as national and regional associations across the world. He will succeed Eduardo Pisani who recently announced his departure after seven years at the helm of IFPMA.
Thomas B. Cueni will leave his role as General Secretary and General Manager of Interpharma (www.interpharma.ch ), positions he has held for 28 years. He will take up his new appointment as Director General of IFPMA on 1st February 2017.
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Morgane De Pol │Manager, Communications and Public Affairs │Tel: +41 22 338 32 20 │
Mobile : +41 79 962 11 95 │ email@example.com │Twitter : @MorganePol
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.Learn more
Media ContactElliot Dunster firstname.lastname@example.org